source
- Kardigan plans $320M IPO for heart drugs as Nasdaq listings gain steamParabilis Medicines' record-breaking IPO will be a tough act to follow, but a drug developer with three late-stage cardio medicines is up for the challenge. It's led by a CEO who sold ...Endpoints · 2mo ago↗ source
- STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and moreMore employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the medicationsSTAT · 2mo ago↗ source
- FDA Issues Emergency Use Authorization for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and CatsFDA today issued an Emergency Use Authorization (EUA) for generic Nitenpyram Tablets (nitenpyram) for the treatment of New World screwworm (NWS) infestations (myiasis) in dogs, puppies, cats, and k…